injection of soy lecithin and HCO-60-[14C]coenzyme Q10 into guinea pigs. As shown in Fig. 2 , the radioactivity was found to be mainly localized in the heart muscle and brown adipose tissue 10min after injection of soy lecithin -[14C]coenzyme Q10. At 24h after the injection, radioactivity was found mainly in the heart muscle, liver and spleen. On the other hand, no significant radioactivity was detected in the heart muscle 24h after injection of HCO-60-[14C]coenzyme Q10 (Fig.  3) . These results strongly suggest that the distribution and retention of [14C]coenzyme Q10 solubilized with soy lecithin-system in heart muscle acting as a targeting tissue of coenzyme Q10, were markedly higher than with the HCO-60 solubilizing system. Table 2 shows the redox levels of [14C]coenzyme Q10 in the heart and liver after intravenous injection of [14C]coenzyme Q10 solubilized with soy lecithin or HCO-60. The redox levels of [14C]coenzyme Q10 in the heart reached 22.5 and 58.1% at 15min and 24h respectively after injection of [14C]coenzyme Q10 solubilized with soy lecithin. In the liver, the redox levels were 26.5 and 67.6% at the same time points, respectively. On the other hand, the redox levels of [14C]coenzvme Q10 in the Q10. This fact is important since the reduced Q10 may play a significant role as an anti-oxidant (6, 7). Thus, the soy lecithin solubilizing system of coenzyme Q10 acted as an excellent delivery system to the heart as a targeting tissue of coenzyme Q10, and may prove to be highly effective in the therapy of heart disease such as myocardial ischemia and adriamycin toxicity.
